To test the relevance of direct arginine-mediated PC autonomous effects on myeloma growth in vivo, we employed the arginase inhibitor, CB1158 to restore arginine concentration in myeloma xenografts into Rag2–/–γc–/– immunocompromised recipient mice. The gene discussed is GC; the disease is plasma cell myeloma.